Wildcat Capital Management, LLC Quant / Systematic

Location: New York, NY

CIK: 0001582384 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 2, 2025

Total Value: $187M (100.0% shares, 0.0% debt)

Holdings (8)

ULCC FRONTIER GROUP HLDGS INC 65.0%
Value $122M Shares 28,061,351 Share Price $4.34 Est. Cost/Share $5.99 Unrealized @ Report Date -27.6%
RLX RLX TECHNOLOGY INC 18.1%
Value $33.93M Shares 18,046,195 Share Price $1.88 Est. Cost/Share $5.25 Unrealized @ Report Date -64.2%
TIC ACUREN CORP 8.9%
Value $16.68M Shares 1,500,000 Share Price $11.12 Est. Cost/Share $12.06 Unrealized @ Report Date -7.8%
URGN UROGEN PHARMA LTD 2.9%
Value $5.481M Shares 495,606 Share Price $11.06 Est. Cost/Share $34.01 Unrealized @ Report Date -67.5%
ALLO ALLOGENE THERAPEUTICS INC 2.3%
Value $4.264M Shares 2,920,787 Share Price $1.46 Est. Cost/Share $17.44 Unrealized @ Report Date -91.6%
CNTA CENTESSA PHARMACEUTICALS PLC 2.2%
Value $4.053M Shares 281,859 Share Price $14.38 Est. Cost/Share $14.38 Unrealized @ Report Date —
— KRONOS BIO INC 0.6%
Value $1.071M Shares 1,297,959 Share Price $0.82 Est. Cost/Share $29.87 Unrealized @ Report Date —
— SILEXION THERAPEUTICS CORP 0.1%
Value $125K Shares 113,428 Share Price $1.10 Est. Cost/Share $2.01 Unrealized @ Report Date —